Funding Eurostars Funding programme, Funded by: BMBF, Submission deadline: 12/09/2019 https://www.gesundheitsindustrie-bw.de/en/database/funding/eurostars
Article - 02/08/2016 Can the ticking Huntington clock be stopped? An early phase clinical study involving thirty-six Huntington’s disease (HD) patients is currently underway to investigate whether a method called gene silencing can cure the disease. If the gene that causes the disease can be turned off, it would be the first step towards a treatment that not only fights symptoms but actually treats the causes of HD, hence providing a cure. https://www.gesundheitsindustrie-bw.de/en/article/news/can-the-ticking-huntington-clock-be-stopped
Article - 28/01/2016 Crowdsourcing initiative to tackle Alzheimer’s The BioMed X Innovation Center and the biopharmaceutical company AbbVie Deutschland GmbH & Co. KG have used crowdsourcing to set up a team of scientists from renowned international institutions to investigate new options for treating Alzheimer’s disease. The team are looking for targets in the metabolism of tau proteins and its pathological modifications that can be used to develop drugs to treat Alzheimer’s disease.https://www.gesundheitsindustrie-bw.de/en/article/news/crowdsourcing-initiative-to-tackle-alzheimers
Press release - 26/08/2015 Immatics Biotechnologies GmbH - new alliances and launch of Immatics US, Inc. MorphoSys and Immatics Biotechnologies Enter Strategic Alliance in Immuno-oncology. Furthermore Immatics and MD Anderson announce launch of Immatics US, Inc., to develop multiple T-cell and TCR-based adoptive cellular therapies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/immatics-biotechnologies-gmbh-new-alliances-and-launch-of-immatics-us-inc
Funding Erasmus for Young Entrepreneurs Scholarship, Funded by: EUhttps://www.gesundheitsindustrie-bw.de/en/database/funding/erasmus-for-young-entrepreneurs
Article - 26/08/2013 International procedures for the detection and identification of GM seeds In Europe the GM contamination threshold must not exceed 0.1. The Agricultural Technology Centre Augustenberg LTZ in Karlsruhe is accredited by the International Seed Testing Association ISTA to carry out international cooperative studies on GM seed analyses in cooperation with ISTA.https://www.gesundheitsindustrie-bw.de/en/article/news/international-procedures-for-the-detection-and-identification-of-gm-seeds
Article - 18/02/2013 Biotechnology in Biberach: a success story that breaks new ground At its New Year reception Biberach University of Applied Sciences outlined the universitys success the establishment of its biotechnology programme is going smoothly and student interest remains steady. Biberach also has a successful track record of acquiring third-party funding and has established new national and international cooperations.https://www.gesundheitsindustrie-bw.de/en/article/news/biotechnology-in-biberach-a-success-story-that-breaks-new-ground
Article - 21/01/2013 Early warning signals of ageing in stem cells The large international project SyStemAge is specifically focused on the role of stem cells in ageing and age-related diseases. Coordinated by the European Molecular Biology Laboratory and the Heidelberg University Hospital the SyStemAge consortium seeks to identify the causes and molecular pathways associated with the processes of ageing on the stem-cell level as well as developing novel strategies for the early treatment of age-related…https://www.gesundheitsindustrie-bw.de/en/article/news/early-warning-signals-of-ageing-in-stem-cells
Press release - 12/11/2012 GATC Biotech joins a new EU research network for young researchers Seven European research institutions and GATC Biotech have formed a consortium providing cutting-edge training in the scientific study of the human past. The BEAN (Bridging the European and Anatolian Neolithic) Initial Training Network has been awarded four years of funding from the European Commission through the Marie Curie Actions program. It is a new multinational and multidisciplinary Marie Curie Research initiative exploring the origins of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-joins-a-new-eu-research-network-for-young-researchers
Article - 10/09/2012 EU cooperations at the interface of research and industry It is also in the interest of small companies to look beyond their national borders: biotechnology and medical technology specialists in neighbouring European countries offer excellent prospects to German companies – and vice versa. Regional life sciences networks help establish and intensify contacts and collaborative activities between international partners.https://www.gesundheitsindustrie-bw.de/en/article/news/eu-cooperations-at-the-interface-of-research-and-industry
Article - 10/09/2012 "BrainLinks-BrainTools" – how an intention becomes reality An accident victim is no longer able to pick up a tea cup because the nerves between the brain and the arm are severed. Researchers from the faculties of biology medicine and technology at the University of Freiburg are able to translate pure thought into the movement of a cursor on a computer screen. The researchers are part of the BrainLinks-BrainTools consortium.https://www.gesundheitsindustrie-bw.de/en/article/news/brainlinks-braintools-how-an-intention-becomes-reality
Article - 03/09/2012 Systems biology and hepatitis C research The international research project SysPatho aims to advance the understanding of HCV (hepatitis C virus) infections using systems biology approaches. The goal of the project coordinated by Universität Heidelberg is to develop new mathematical and computational methods to reconstruct HCV-infected hepatocytes, which can be used to identify new drug targets and help treat this dangerous disease.https://www.gesundheitsindustrie-bw.de/en/article/news/systems-biology-and-hepatitis-c-research
Article - 18/06/2012 National biobanks for scientific research Biobanks are of key importance for biomedical research and for improving diagnostics and therapies involving new biomarkers. The German Federal Ministry of Education and Research is funding the National Biobank Initiative with a total of around 18 million euros. The initiative aims to standardize and combine the resources of five model locations, including the BioMaterialBank Heidelberg which integrates the tissue bank of the National Centre for…https://www.gesundheitsindustrie-bw.de/en/article/news/national-biobanks-for-scientific-research
Press release - 16/05/2012 OGpharma in China OGpharma (CEO: Dr. Wanzhou ZHAO) is a Contract Research Company (CRO) located in Nanjing’s Gulou Science Park. The company offers two services: a) contract research, and b) consulting service for international cooperation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ogpharma-in-china
Press release - 14/03/2012 New method provides insights into cell movement In wound healing and the growth and spread of tumours a particular characteristic of the bodys cells plays a crucial role their capacity to move in their tissue environment. Together with colleagues from Japan scientists from the Max Planck Institute for Intelligent Systems in Stuttgart and the University of Heidelberg have developed a very promising method for the study of cell movement. The new method enables the examination of the collective…https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-method-provides-insights-into-cell-movement
Press release - 09/02/2012 European tool enables companies to open up markets BioRegio STERN Management GmbH is one of five project partners in BIOMAT-In. This transnational EU project promotes innovations and cooperation in the biomaterials sector and is being funded for three years with a total of EUR 1.24 million. BioRegio STERN Management GmbH is committed to creating a successful pan-European cluster in regenerative medicine and tissue engineering. It is receiving EUR 223,000 during this period to develop a…https://www.gesundheitsindustrie-bw.de/en/article/press-release/european-tool-enables-companies-to-open-up-markets
Article - 17/10/2011 “The only way of keeping competition in the international market at bay” Biotech companies operate mostly on a global level. This is either because they follow their customers or because their major markets are abroad or because their domestic markets are so small that they are obliged to market their products abroad. Patents do not play a key role in all industries, but are of decisive strategic importance in the biotechnology sector. "However, patents are not always the best," says Ulrike Cremer, a patent…https://www.gesundheitsindustrie-bw.de/en/article/news/the-only-way-of-keeping-competition-in-the-international-market-at-bay
Press release - 24/08/2011 The project ANTIGONE aims at responding to unexpected epidemic threats The European Commission has decided to allocate an additional 12 million euro from the EU's Research Framework Programme to reinforce Europe's capacity for tackling pathogens like the virulent Escherichia coli (E.coli) bacteria that recently infected close to 4,000 people in Europe and killed 46. The project will also try to identify possible ways of eradicating diseases and draw lessons that may help prevent threats in the future.https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-project-antigone-aims-at-responding-to-unexpected-epidemic-threats
Press release - 29/03/2011 Freiburg Regional Council to fund MedicalMountains cluster initiative The Freiburg Regional Council has granted MedicalMountains AG funds totalling 405,000 euros for establishing a professional management structure for the Tuttlingen-based medical technology cluster. District President Julian Würtenberger awarded the 405,000-euro grant to Dieter Teufel, president of the Schwarzwald-Baar-Heuberg Chamber of Industry and Commerce and representative of the Tuttlingen-based cluster, in which BIOPRO Baden-Württemberg…https://www.gesundheitsindustrie-bw.de/en/article/press-release/freiburg-regional-council-to-fund-medicalmountains-cluster-initiative
Article - 03/12/2010 Review: Science meets Business Day 2010 (part I) Germinating seeds biosensors in the human body deaf people learning to hear again and new approaches to combat the flu virus the lectures held at the Science meets Business Day which concluded this years BioValley Science Week once again highlighted the innovations brought about through the joint efforts of research and industrial players on the Upper Rhine. https://www.gesundheitsindustrie-bw.de/en/article/news/review-science-meets-business-day-2010-part-i
Press release - 26/11/2010 Singapore meets Baden-Württemberg: biotechnology and medical technology companies exchange views Several biotechnology and medical technology companies from Baden-Wüttemberg and Singapore interested in international cooperation met in Stuttgart on 19th November 2010. The event was organised by SRING Singapore Enterprise and BIOPRO Baden-Württemberg GmbH.https://www.gesundheitsindustrie-bw.de/en/article/news/singapore-meets-baden-wuerttemberg-biotechnology-and-medical-technology-companies-exchange-views
Press release - 16/11/2010 Summit conference on regional development in the Rhine-Neckar Metropolitan Region To learn from leading regional developers this was the goal set by the representatives of the Biotechnology Cluster Rhine-Neckar BioRN for the Regional Development Summit. Representatives from business science and politics in the Rhine-Neckar Metropolitan Region met in the Villa Bosch in Heidelberg on November 11 with experts from the leading international high-tech sites in Leuven Belgium Cambridge UK and Israel. https://www.gesundheitsindustrie-bw.de/en/article/press-release/summit-conference-on-regional-development-in-the-rhine-neckar-metropolitan-region
Press release - 09/09/2010 Nanjing University of Technology Nanjing – Jiangsu’s capital with a population of over 6 million – has over 20 universities. There are two technical universities, Nanjing University of Science and Technology (NJUST) and Nanjing University of Technology (NJUT), which originates from the Nanjing University of Chemical Technology.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanjing-university-of-technology
Press release - 08/04/2010 Next step towards international cooperation Representatives from companies and research institutes based in the STERN BioRegion met metalworking and surface treatment specialists in France. The collaboration between BioRegio STERN Management GmbH and Ple Technologique de Haute-Champagne PTHC opens up the way for making new contacts sharing innovative ideas and exploring cooperation options.https://www.gesundheitsindustrie-bw.de/en/article/press-release/next-step-towards-international-cooperation
Article - 25/01/2010 Treatment and Research Centre of Rare Diseases established in Tübingen On 22nd January 2010, the first German Treatment and Research Centre of Rare Diseases (ZSE) was officially opened in Tübingen. Interdisciplinary teams will from now on be developing new therapies under one roof for around three to four million patients suffering from rare diseases in Germany. The centre in Tübingen will offer optimal patient treatment, coordinate the cooperation between international specialists, and provide competent advice and…https://www.gesundheitsindustrie-bw.de/en/article/news/treatment-and-research-centre-of-rare-diseases-established-in-tuebingen